Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2025-12-25 @ 1:46 AM
NCT ID:
NCT00296894
Brief Summary:
Patients will be randomized into two groups (1/1) during one year:
* 40 mg adalimumab subcutaneously (sc) every other week
* placebo
The effect on x-rays and clinical parameters will be evaluated.
Study:
NCT00296894
Study Brief:
Protocol Section:
NCT00296894